Full Text View
Tabular View
No Study Results Posted
Related Studies
Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
This study has been completed.
Study NCT00244023   Information provided by SELARL du Dr Jacques BUVAT

First Received on October 23, 2005.   Last Updated on August 22, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Erectile Dysfunction
Hypogonadism
More general conditions related to this trial
Endocrine System Diseases
Genital Diseases, Male
Gonadal Disorders
Mental Disorders
Sexual and Gender Disorders
Sexual Dysfunction, Physiological
Sexual Dysfunctions, Psychological
Interventions listed in this trial
Testosterone gel
testosterone
placebo gel
Additional drug interventions recognized in this trial
Methyltestosterone
Phosphodiesterase 5 Inhibitors
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Enzyme Inhibitors
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
SELARL du Dr Jacques BUVAT
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services